Short- and long-term risk of cardiovascular events in white-coat hypertension (Q44990120)

8 December 2017

title

Short- and long-term risk of cardiovascular events in white-coat hypertension (English)

1 reference

8 December 2017

S D Pierdomenico

1

1 reference

8 December 2017

D Lapenna

series ordinal

2

1 reference

8 December 2017

R Di Mascio

series ordinal

3

1 reference

8 December 2017

F Cuccurullo

series ordinal

4

1 reference

8 December 2017

publication date

21 February 2008

1 reference

Journal of Human Hypertension

8 December 2017

published in

1 reference

8 December 2017

volume

22

1 reference

8 December 2017

issue

6

1 reference

8 December 2017

page(s)

408-414

1 reference

How common is white coat hypertension?

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Cardiovascular Risk In White-coat and Sustained Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Target Organ Status and Serum Lipids in Patients With White Coat Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Properly defining white coat hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

How common is white coat hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

‘White-coat’ hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

White coat effect, blood pressure and mortality in men: prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Short- and Long-Term Incidence of Stroke in White-Coat Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension. Results of the HALT Study. Hypertension and Lipid Trial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.6

7 January 2021

Identifiers

DOI

10.1038/JHH.2008.6

1 reference

8 December 2017

1 reference